Redirecting tumor-associated macrophages to become tumoricidal effectors as a novel strategy for cancer therapy
-
- Xiang Zheng
- Max Planck Institute for Heart and Lung Research, Department of Lung Development and Remodeling, Member of the German Center for Lung Research (DZL), Bad Nauheim, Germany
-
- Kati Turkowski
- Max Planck Institute for Heart and Lung Research, Department of Lung Development and Remodeling, Member of the German Center for Lung Research (DZL), Bad Nauheim, Germany
-
- Javier Mora
- Institute of Biochemistry I, Goethe-University Frankfurt, Frankfurt, Germany
-
- Bernhard Brüne
- Institute of Biochemistry I, Goethe-University Frankfurt, Frankfurt, Germany
-
- Werner Seeger
- Max Planck Institute for Heart and Lung Research, Department of Lung Development and Remodeling, Member of the German Center for Lung Research (DZL), Bad Nauheim, Germany
-
- Andreas Weigert
- Institute of Biochemistry I, Goethe-University Frankfurt, Frankfurt, Germany
-
- Rajkumar Savai
- Max Planck Institute for Heart and Lung Research, Department of Lung Development and Remodeling, Member of the German Center for Lung Research (DZL), Bad Nauheim, Germany
収録刊行物
-
- Oncotarget
-
Oncotarget 8 (29), 48436-48452, 2017-04-12
Impact Journals, LLC